Protocol to assess self-renewal capacity and post-treatment line derivation using an organoid drug resistance assay
Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.
Authors
- Anca Chelariu-Raicu (ORCID: https://orcid.org/0000-0003-2944-9488)
- Mirjana Kessler (ORCID: https://orcid.org/0000-0002-9879-1052)
- Juliane Reichenbach (ORCID: https://orcid.org/0000-0001-6124-1893)
- Alexander Burges (ORCID: https://orcid.org/0000-0002-9693-366X)
- Fabian B. T. Kraus (ORCID: https://orcid.org/0000-0002-9338-9646)
- Bastian Czogalla (ORCID: https://orcid.org/0000-0001-6589-4736)
- Fabian Trillsch (ORCID: https://orcid.org/0000-0002-1860-4350)
- Sophia Hierlmayer
- Sophia Geweniger
- Sven� Mahner (ORCID: https://orcid.org/0000-0002-2224-5709)
- Tingyu Zhang
- Juliana Schmid
Institutions
- LMU Klinikum (DE)
- Deutsches Konsortium für Translationale Krebsforschung (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- STAR Protocols
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1016/j.xpro.2026.104961
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bundesministerium für Bildung und Forschung
- Deutsche Krebshilfe